Fredun Pharmaceuticals standalone net profit rises 215.07% in the March 2022 quarter

17 May 2022 , 08:13 AM

Net profit of Fredun Pharmaceuticals rose 215.07% to Rs 2.30 crore in the quarter ended March 2022 as against Rs 0.73 crore during the previous quarter ended March 2021. Sales rose 68.90% to Rs 69.45 crore in the quarter ended March 2022 as against Rs 41.12 crore during the previous quarter ended March 2021. For the full year,net profit rose 215.42% to Rs 6.34 crore in the year ended March 2022 as against Rs 2.01 crore during the previous year ended March 2021. Sales rose 68.56% to Rs 221.74 crore in the year ended March 2022 as against Rs 131.55 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	69.45	41.12	69	221.74	131.55	69
OPM %	7.76	6.86	–	6.96	8.00	–
PBDT	3.67	1.53	140	10.76	6.36	69
PBT	3.09	1.01	206	8.60	4.36	97
NP	2.30	0.73	215	6.34	2.01	215

Powered by Capital Market – Live News